Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.

We have examined the relationship between serum insulin-like growth factor-I (IGF-I) and prostate-specific antigen in 367 healthy men without evidence of prostate cancer and found a positive association (P = 0.05). In men without prostate cancer, serum prostate-specific antigen is closely related to...

Full description

Bibliographic Details
Main Authors:	Oliver, SE, Barrass, B, Gunnell, D, Donovan, J, Peters, T, Persad, R, Gillatt, D, Neal, D, Hamdy, F, Holly, J
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Are diet-prostate cancer associations mediated by insulin-like growth factors? Cross-sectional analysis of diet-IGF associations in middle-aged men
by: Gunnell, D, et al.
Published: (2002)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
by: Oliver, SE, et al.
Published: (2004)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
by: Oliver, SE, et al.
Published: (2002)

Screen-detected prostate cancer and the insulin-like growth factor (IGF)-axis: Results of a case-control study
by: Oliver, SE, et al.
Published: (2002)

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men.
by: Gunnell, D, et al.
Published: (2003)

Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study.
by: Oliver, SE, et al.
Published: (2004)

Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease?
by: Gunnell, D, et al.
Published: (2004)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
by: Brindle, L, et al.
Published: (2006)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
by: Burton, A, et al.
Published: (2011)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
by: Hamdy, F, et al.
Published: (2006)

Dietary and Serum Antioxidants Associated with Prostate-Specific Antigen for Middle-Aged and Older Men
by: Hui-Yi Lin, et al.
Published: (2023-07-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
by: Ebenezer Abotsi, et al.
Published: (2022-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
by: Donovan, J, et al.
Published: (2003)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
by: Rosario, D, et al.
Published: (2012)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
by: Down, L, et al.
Published: (2011)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
by: Down, L, et al.
Published: (2011)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
by: Avery, K, et al.
Published: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
by: Avery, K, et al.
Published: (2012)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
by: Hamdy, F, et al.
Published: (2006)

Evaluation of serum prostatic-specific antigen levels in diabetic and non-diabetic men diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2022-01-01)

Post-diagnosis serum insulin-like growth factors in relation to dietary and lifestyle changes in the Prostate testing for cancer and Treatment (ProtecT) trial.
by: Er, V, et al.
Published: (2017)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
by: Macefield, R, et al.
Published: (2009)

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer
by: Elton Llukani, et al.
Published: (2017-03-01)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
by: Collin, S, et al.
Published: (2010)

Association between serum 25-hydroxyvitamin D and prostate-specific antigen: a retrospective study in men without prostate pathology
by: Laguna Javier, et al.
Published: (2023-10-01)

The role of the serum 25-OH vitamin D level on detecting prostate cancer in men with elevated prostate-specific antigen levels
by: Min Hyuk Kim, et al.
Published: (2022-08-01)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
by: Tilling, K, et al.
Published: (2010)

Screening for prostate cancer. The case against.
by: Donovan, J, et al.
Published: (2005)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
by: Moore, A, et al.
Published: (2009)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
by: Vickers, A, et al.
Published: (2010)

10-year outcomes in localized prostate cancer.
by: Hamdy, F, et al.
Published: (2017)

Prostate cancer: screening approaches
by: Donovan, J, et al.
Published: (2005)

Prostate cancer: screening approaches.
by: Donovan, J, et al.
Published: (2005)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
by: Young, GJ, et al.
Published: (2017)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
by: le Roux, C, et al.
Published: (2002)

Relationship between serum prostate-specific antigen and age in cadavers
by: Hajime Tsuboi, et al.
Published: (2020-09-01)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
by: Avery, K, et al.
Published: (2008)

Screening for prostate cancer remains controversial.
by: Neal, D, et al.
Published: (2009)